EPISODE · Dec 12, 2025 · 29 MIN
029. Valeant: Drug Prices, Accounting Tactics, and a Pharma Reckoning
from Beneath Suspicion
All episodes of this podcast are fully researched, written, and edited by our human production team. The final audio is generated using text-to-speech technology to deliver consistent narration quality and listening experience.----------------The pharmaceutical company that grew through acquisitions and price hikes until questions about its business model sent shares into freefall. Hosted on Acast. See acast.com/privacy for more information.
What this episode covers
All episodes of this podcast are fully researched, written, and edited by our human production team. The final audio is generated using text-to-speech technology to deliver consistent narration quality and listening experience.----------------The pharmaceutical company that grew through acquisitions and price hikes until questions about its business model sent shares into freefall. Hosted on Acast. See acast.com/privacy for more information.
NOW PLAYING
029. Valeant: Drug Prices, Accounting Tactics, and a Pharma Reckoning
No transcript for this episode yet
Similar Episodes
Apr 30, 2026 ·30m
Apr 13, 2026 ·43m
Apr 11, 2026 ·3m
Mar 19, 2026 ·41m
Feb 19, 2026 ·64m